menu
    • menu

    Company profile for Janssen-Cilag

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Janssen-Cilag is a Johnson & Johnson company . For more than a century, since its foundation in 1886 in the US state of New Jersey, Johnson & Johnson has linked its name to wellness and health care .After an initial presence concentrated on the American market , in 1919 the Group expanded internationally with the opening of Johnson & Johnson Canada . Over the next 50 years, marked by a constant growth of the activities , offic...
    Janssen-Cilag is a Johnson & Johnson company . For more than a century, since its foundation in 1886 in the US state of New Jersey, Johnson & Johnson has linked its name to wellness and health care .After an initial presence concentrated on the American market , in 1919 the Group expanded internationally with the opening of Johnson & Johnson Canada . Over the next 50 years, marked by a constant growth of the activities , offices are opened in Latin America, Africa, Australia and Europe . 1944 was the year of the listing on the New York Stock Exchange (NYSE).

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Janssen-CilagItaly Flag
    Country
    Country
    Italy
    Address
    Address
    Via Michelangelo Buonarroti 23, 20093 Cologno Monzese
    Telephone
    Telephone
    +39 800 688 777
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.janssen.com/italy/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/janssen-cilag-s.p.a./about/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/JanssenITA

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    RYBREVANT & LAZCLUZE May Improve Survival in Lung Cancer
    RYBREVANT & LAZCLUZE May Improve Survival in Lung Cancer

    07 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/07/3145711/0/en/Data-published-in-The-New-England-Journal-of-Medicine-demonstrate-RYBREVANT-amivantamab-plus-LAZCLUZE-lazertinib-could-re-set-survival-expectations-in-first-line-EGFR-mutated-advan.html

    GLOBENEWSWIRE
    07 Sep 2025
    Share Share
    Nipocalimab better than FcRn blockers for gMG in 24-week study
    Nipocalimab better than FcRn blockers for gMG in 24-week study

    25 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/25/3104815/0/en/Nipocalimab-showed-greater-sustained-disease-control-versus-approved-FcRn-blockers-for-generalised-myasthenia-gravis-gMG-at-multiple-timepoints-over-24-weeks-in-newly-published-ind.html

    GLOBENEWSWIRE
    25 Jun 2025
    Share Share
    Talvey + Tecvayli Combo Shows Deep Responses in Myeloma
    Talvey + Tecvayli Combo Shows Deep Responses in Myeloma

    15 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/15/3099407/0/en/Investigational-combination-of-first-in-class-bispecific-antibodies-TALVEY-talquetamab-and-TECVAYLI-teclistamab-shows-deep-and-durable-responses-in-heavily-pretreated-multiple-myel.html

    GLOBENEWSWIRE
    15 Jun 2025
    Share Share
    IMBRUVICA Combo Shows Edge Over Acalabrutinib in CLL
    IMBRUVICA Combo Shows Edge Over Acalabrutinib in CLL

    12 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/12/3098040/0/en/Significant-efficacy-benefit-of-IMBRUVICA-ibrutinib-plus-venetoclax-versus-acalabrutinib-plus-venetoclax-in-frontline-treatment-of-patients-with-chronic-lymphocytic-leukaemia-sugge.html

    GLOBENEWSWIRE
    12 Jun 2025
    Share Share
    Darzalex Subcutaneous Regimen Benefits Newly Diagnosed Myeloma
    Darzalex Subcutaneous Regimen Benefits Newly Diagnosed Myeloma

    03 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/03/3092971/0/en/New-analyses-reinforce-long-term-benefit-of-DARZALEX-daratumumab-subcutaneous-based-quadruplet-regimen-for-patients-with-newly-diagnosed-multiple-myeloma.html

    GLOBENEWSWIRE
    03 Jun 2025
    Share Share
    Tremfya approved by European Commission for ulcerative colitis
    Tremfya approved by European Commission for ulcerative colitis

    25 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/25/3068097/0/en/TREMFYA-guselkumab-receives-European-Commission-approval-for-adults-with-moderately-to-severely-active-ulcerative-colitis-strengthening-Johnson-Johnson-s-leadership-in-inflammatory.html

    GLOBENEWSWIRE
    25 Apr 2025
    Share Share

    ABOUT THIS PAGE

    Contact Janssen-Cilag and get a quotation

    Janssen-Cilag is a supplier offers 1 products (APIs, Excipients or Intermediates).

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN BORGO SAN MICHELE, ITALY bulk offered by Janssen-Cilag

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search